StockGlow

CapForce Inc. (CFOR)

Develops rapid genetic tests that identify dangerous infections and antibiotic resistance in hospitals.

$9.51-0.47%Financial Services
Compare CFOR with
StockGlow Score
32
Leaning Bearish
BearishBullish
1 year ago+102.3%

The outlook

CFOR is trading near the lower end of its 52-week range at $9.51, with analyst sentiment leaning bearish overall. The stock sits mixed relative to its moving averages, and the trailing P/E of 4.1 suggests a low valuation multiple compared to recent earnings.

What’s behind the score

Price trendMixed vs its moving averages
52-week range28% of the way from its 52-week low to high
Market cap
$117.8M
52-wk high
$34.00
52-wk low
$0.00
50-day avg
$8.32
200-day avg
$12.71
Trailing P/E
4.1

Similar stocks

AYTUAytu BioPharma, Inc.$2.15+4.37%PRPOPrecipio, Inc.$23.04+0.51%VTVTvTv Therapeutics Inc.$31.12+0.31%TENXTenax Therapeutics, Inc.$15.59-3.71%AIMAIM ImmunoTech Inc.$0.24-4.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy